GIOTRIF® 妥復克®

For the treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumours have activating epidermal growth factor receptor (EGFR) mutations. For the treatment of patients with locally advanced or metastatic NSCLC of squamous histology progressing on or after platinum based chemotherapy.

點擊放大

Product Key Facts

中文仿單

GIOTRIF®

afatinib

透過新聞瞭解更多資訊，請見【 肺癌】頁面

References